Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
giovanna.poce@uniroma1.it
Giovanna Poce
Professore Associato
Struttura:
DIPARTIMENTO DI CHIMICA E TECNOLOGIE DEL FARMACO
E-mail:
giovanna.poce@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery
PHARMACEUTICS
2024
Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances
PHARMACEUTICALS
2023
Tannin microcapsules for synergy-enhanced sunscreen formulations
INDUSTRIAL CROPS AND PRODUCTS
2023
Antiviral Mechanisms of N-Phenyl Benzamides on Coxsackie Virus A9
PHARMACEUTICS
2023
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment
PHARMACEUTICS
2022
Malaria transmission blocking compounds: a patent review
EXPERT OPINION ON THERAPEUTIC PATENTS
2022
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment
PHARMACEUTICS
2022
Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2021
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2021
A novel class of dual-acting DCH-CORMs counteracts oxidative stress-induced inflammation in human primary tenocytes
ANTIOXIDANTS
2021
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy
SEMINARS IN CANCER BIOLOGY
2020
Sar analysis of small molecules interfering with energy-metabolism in mycobacterium tuberculosis
PHARMACEUTICALS
2020
Overcoming drug resistance in TB: An update
FUTURE MICROBIOLOGY
2020
Novel therapies for glaucoma: a patent review (2013-2019)
EXPERT OPINION ON THERAPEUTIC PATENTS
2019
Mycobacterial tryptophan biosynthesis: a promising target for tuberculosis drug development?
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
2019
Novel pyrazole-containing compounds active against mycobacterium tuberculosis
ACS MEDICINAL CHEMISTRY LETTERS
2019
Chocolate consumers and lymphocyte-to-monocyte ratio: a working hypothesis from a preliminary report of a pilot study in celiac subjects
ANTIOXIDANTS
2019
Development of MmpL3 inhibitors for tuberculosis treatment
Medicinal Chemistry approaches to tuberculosis and trypanosomiasis
2019
In vivo potent BM635 analogue with improved drug-like properties
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2018
Stimuli-responsive tannin–feIII hybrid microcapsules demonstrated by the active release of an anti-tuberculosis agent
CHEMSUSCHEM
2018
1
2
seguente ›
ultima »
Progetti di Ricerca
Nuovi derivati pirazolici come potenziali agenti anti-tubercolari
Nuovi derivati tri-antranilati come potenziali agenti anti-tubercolari
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma